Cambridge Scientists Create A $10 Chip That Could Put A Medical Lab On Your Wrist

TL;DR

For listenersOffer from Amazon

Turn your wind-down time into listening time

• Thousands of audiobooks, podcasts and originals
• Listen on your phone, tablet or Echo — also offline
• Cancel anytime

Try Audible free →Free trial for new members

As an affiliate, we earn on qualifying purchases.Hide

Researchers at the University of Cambridge and start-up GlitterinTech report developing a compact optical spectrometer with an estimated cost of $10. In reported tests, it classified several materials and measured solutions and biomarkers, including glucose, but the work does not establish that it is ready for medical use or a wrist-worn product.

Researchers at the University of Cambridge and the start-up GlitterinTech report developing a compact optical spectrometer estimated to cost $10, with tests that included identifying materials and measuring human biomarkers. The results point to possible uses in portable sensors and health monitoring, but the device has not been established as a consumer wearable or a clinically validated glucose monitor.

The device, described as a convolutional spectrometer, is built on a silicon nitride photonic platform and integrated with onboard electronics. It measures near-infrared light across wavelengths of 1,200 to 1,700 nanometers and can collect and process measurements in less than a second, according to the research report. Optical spectrometers infer information about substances by analyzing how they interact with light.

The team says its design performs convolution directly on incoming light using a sequence of optical components with repeating spectral responses. Fast Fourier transforms are then used to recover the spectrum. The researchers report that the system operated between -20°C and 80°C, and that adding optical components could raise resolution while extending the measurement bandwidth without major hardware changes.

In reported tests, the device classified samples of plastics, pharmaceuticals, coffee, flour and tea with 100% success. It measured concentrations in water-based and organic solutions with reported accuracy of about 0.01%. The researchers also tested skin moisture, blood alcohol, blood lactate and blood glucose. One demonstration tracked glucose noninvasively over an extended period in a single participant; that result is not evidence of performance across a wider patient population.

From Bench Instruments to Portable Sensors

If later studies reproduce the reported results, a low-cost, small spectrometer could make some light-based measurements available in settings where full-sized laboratory equipment is impractical. Potential applications identified by the researchers include wearable health technology, food testing, industrial quality control and environmental monitoring. The ability to gather results in under a second could also suit portable or continuous sensing, though the source does not establish that the device has been incorporated into a wrist-worn product.

The glucose demonstration has particular relevance because it suggests a possible way to monitor blood sugar without repeated skin punctures. But a laboratory demonstration in one participant does not show that the technology is accurate, safe or reliable enough for diabetes management. A clinical product would need broader validation and assessment under real-world conditions. The reported $10 cost likewise does not by itself establish the price of a finished wearable or medical device.

Why Miniaturized Spectrometers Fall Short

Conventional spectrometers often separate light into wavelengths or use calculations to reconstruct a spectrum. According to the researchers, shrinking those instruments has commonly involved trade-offs, including limited measurement ranges, lower resolution or reduced accuracy. Compact devices may identify substances without matching the precision needed for some quantitative measurements.

The Cambridge team says its approach uses the convolution theorem to process light in a different way, with repeating optical patterns arranged so their response shifts across wavelengths. The project was conducted by university researchers and GlitterinTech, a start-up founded by the same research group. The source describes the device as a packaged system, but does not provide details here about independent replication, regulatory review or commercial availability.

“The key insight was to go back to the mathematics and ask whether there was a fundamentally cleaner way to retrieve spectra.”

— Dr. Chunhui Yao, lead author

Medical Validation Is Still Needed

The reported experiments do not establish how accurately the sensor would measure glucose across different people, skin types, activity levels or everyday conditions. The source specifically says further testing is needed before the technology could become a practical medical product. It does not give a clinical trial size beyond noting that the extended noninvasive glucose demonstration involved one participant, nor does it describe comparison with established glucose-monitoring methods.

It is also unclear whether the reported $10 figure is a component cost, a prototype estimate or a projected manufacturing cost at scale. The report does not specify a commercial launch date, regulatory status or whether a wrist-worn version has been built. Claims of 100% classification and approximately 0.01% accuracy apply to the reported tests and should not be read as guarantees for other samples or settings.

Further Tests Before Consumer Use

The next step is additional testing, especially for the biomedical measurements and noninvasive glucose tracking. Larger studies would be needed to establish how the sensor performs across participants and conditions and whether it can provide dependable readings outside the research setup. The available report does not announce a clinical study schedule or a product release date.

Researchers and potential developers would also need to clarify manufacturing costs, validate the device against appropriate reference instruments, and determine what regulatory review would apply to medical uses. Until those details are available, the spectrometer is best understood as a research development with reported laboratory demonstrations, not an approved health-monitoring device.

Key Questions

What did the Cambridge team develop?

The researchers report developing a compact optical spectrometer that analyzes light to measure properties of substances. It uses a convolution-based design and onboard electronics.

Can it already monitor glucose in a wearable?

The report describes noninvasive glucose tracking over an extended period in one participant. It does not say that a wrist-worn product is available or that the device is validated for routine medical decisions.

What does the $10 figure mean?

The source describes the sensor as costing $10, but does not clarify whether that is a component cost, prototype estimate or expected production cost. It should not be treated as the confirmed retail price of a finished device.

What other tests did the researchers report?

The team reports classifying plastics, pharmaceuticals, coffee, flour and tea, measuring concentrations in two kinds of solutions, and testing biomarkers including skin moisture, blood alcohol, lactate and glucose.

What needs to happen before medical use?

Further validation is needed, including testing across more people and conditions and comparison with established measurement methods. The report does not provide a clinical timetable, regulatory status or launch date.

Source: rss